On August 7, Hims & Hers Health Inc. rose 5.02% in regular trading, trading at $31.16 per share, with turnover of approximately $85.33 million.

On the news front, peer company Hinge Health, which operates in the same healthcare services sector, reported Q2 revenue of $213 million, exceeding market expectations and representing a 53% year-over-year increase. Hinge Health surged over 11% on the day, boosting broader telehealth sector sentiment. Hims & Hers Health Inc. is scheduled to release its Q2 earnings on August 10 after market close, with consensus estimates projecting revenue of approximately $700 million, representing 26.88% year-over-year growth. The peer earnings beat reinforced investor optimism ahead of the company's own report.

Additionally, the stock had previously declined sharply following FTC litigation alleging improper sharing of user health data with Meta and Snap. Shares have been gradually recovering from that pullback, with current valuation levels attracting capital inflows despite ongoing legal uncertainties including a recently announced federal securities law investigation by a law firm representing investors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)